Skip to content

Higher vs. Lower Dose Heparin for PCI

Cardiovascular Diseases | Percutaneous Coronary Intervention

HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

- Patients undergoing elective PCI

Exclusion Criteria:

* Age \<18 years
* Planned chronic total occlusion PCI
* Non-resident precluding follow up through local registries

Hospital (Cluster) Eligibility Criteria

Hospitals will be eligible to participate if they meet the following criteria:

* Submit PCI procedure data to a compatible registry that is able to provide data for the trial
* Site agrees to manage patients as per the higher or lower dose heparin policy in place during the given crossover period

Lieu de l'étude

Hamilton Health Sciences, General Hospital
Hamilton Health Sciences, General Hospital
Hamilton, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Sanjit Jolly, MD

[email protected]
Étude parrainée par
Population Health Research Institute
Participants recherchés
Plus d'informations
ID de l'étude: NCT04049591